468 related articles for article (PubMed ID: 15214873)
21. Investigation of risk factors for tonsillopharyngitis with macrolide resistant Streptococcus pyogenes in Turkish children.
Ciftçi E; Dogru U; Güriz H; Aysev D; Ince E
Pediatr Int; 2002 Dec; 44(6):647-51. PubMed ID: 12421263
[TBL] [Abstract][Full Text] [Related]
22. Once-daily amoxicillin versus twice-daily penicillin V in group A beta-haemolytic streptococcal pharyngitis.
Lennon DR; Farrell E; Martin DR; Stewart JM
Arch Dis Child; 2008 Jun; 93(6):474-8. PubMed ID: 18337284
[TBL] [Abstract][Full Text] [Related]
23. Comparison of hospitalization rates in patients with community-acquired pneumonia treated with 10 days of telithromycin or clarithromycin.
Niederman MS; Chang JR; Stewart J; Nusrat R; Nieman RB
Curr Med Res Opin; 2004 May; 20(5):749-56. PubMed ID: 15140342
[TBL] [Abstract][Full Text] [Related]
24. Comparison of cefdinir and penicillin V in the treatment of pediatric streptococcal tonsillopharyngitis.
Pichichero ME; Gooch WM
Pediatr Infect Dis J; 2000 Dec; 19(12 Suppl):S171-3. PubMed ID: 11144400
[TBL] [Abstract][Full Text] [Related]
25. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
Mazzariol A; Koncan R; Vitali LA; Cornaglia G
J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
[TBL] [Abstract][Full Text] [Related]
26. Comparison of hospitalization rates in patients with community-acquired pneumonia treated with telithromycin for 5 or 7 days or clarithromycin for 10 days.
Tellier G; Chang JR; Asche CV; Lavin B; Stewart J; Sullivan SD
Curr Med Res Opin; 2004 May; 20(5):739-47. PubMed ID: 15140341
[TBL] [Abstract][Full Text] [Related]
27. Multicentre evaluation of azithromycin and penicillin V in the treatment of acute streptococcal pharyngitis and tonsillitis in children.
Hamill J
J Antimicrob Chemother; 1993 Jun; 31 Suppl E():89-94. PubMed ID: 8396102
[TBL] [Abstract][Full Text] [Related]
28. Pharmacodynamic analysis and clinical trial of amoxicillin sprinkle administered once daily for 7 days compared to penicillin V potassium administered four times daily for 10 days in the treatment of tonsillopharyngitis due to Streptococcus pyogenes in children.
Pichichero ME; Casey JR; Block SL; Guttendorf R; Flanner H; Markowitz D; Clausen S
Antimicrob Agents Chemother; 2008 Jul; 52(7):2512-20. PubMed ID: 18332170
[TBL] [Abstract][Full Text] [Related]
29. [Current Streptococcus pyogenes sensitivity responsible for acute tonsillopharyngitis in France].
Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
Presse Med; 2004 Jun; 33(11):703-6. PubMed ID: 15257225
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the efficacy, safety and toleration of azithromycin vs. penicillin V in the treatment of acute streptococcal pharyngitis in children: results of a multicenter, open comparative study. The Swiss Tonsillopharyngitis Study Group.
Schaad UB; Heynen G
Pediatr Infect Dis J; 1996 Sep; 15(9):791-5. PubMed ID: 8878223
[TBL] [Abstract][Full Text] [Related]
31. Treatment of pediatric patients with acute group A beta-hemolytic streptococcal tonsillopharyngitis.
Jakob-Sölder B; Steininger C; Eigentler A; Allerberger F
Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):811-2. PubMed ID: 9923529
[No Abstract] [Full Text] [Related]
32. Clarithromycin suspension vs penicillin V suspension in children with streptococcal pharyngitis.
McCarty J; Hedrick JA; Gooch WM
Adv Ther; 2000; 17(1):14-26. PubMed ID: 10915400
[TBL] [Abstract][Full Text] [Related]
33. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
[TBL] [Abstract][Full Text] [Related]
34. Variables influencing bacteriological outcome in patients with streptococcal tonsillopharyngitis treated with penicillin V.
Ovetchkine P; Levy C; de la Rocque F; Boucherat M; Bingen E; Cohen R
Eur J Pediatr; 2002 Jul; 161(7):365-7. PubMed ID: 12111186
[TBL] [Abstract][Full Text] [Related]
35. Higher dosages of azithromycin are more effective in treatment of group A streptococcal tonsillopharyngitis.
Casey JR; Pichichero ME
Clin Infect Dis; 2005 Jun; 40(12):1748-55. PubMed ID: 15909262
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of penicillin vs. amoxicillin in children with group A beta hemolytic streptococcal tonsillopharyngitis.
Curtin-Wirt C; Casey JR; Murray PC; Cleary CT; Hoeger WJ; Marsocci SM; Murphy ML; Francis AB; Pichichero ME
Clin Pediatr (Phila); 2003 Apr; 42(3):219-25. PubMed ID: 12739920
[TBL] [Abstract][Full Text] [Related]
37. Susceptibility of Streptococcus pyogenes to two macrolides in northern Israel.
Sakran W; Raz R; Chazan B; Koren A; Colodner R
Int J Antimicrob Agents; 2004 May; 23(5):517-9. PubMed ID: 15120735
[TBL] [Abstract][Full Text] [Related]
38. Metaanalysis of short course antibiotic treatment for group a streptococcal tonsillopharyngitis.
Casey JR; Pichichero ME
Pediatr Infect Dis J; 2005 Oct; 24(10):909-17. PubMed ID: 16220091
[TBL] [Abstract][Full Text] [Related]
39. Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.
Mazzariol A; Koncan R; Bahar G; Cornaglia G
J Chemother; 2007 Oct; 19(5):500-7. PubMed ID: 18073148
[TBL] [Abstract][Full Text] [Related]
40. Development of macrolide-resistance and comparative activity of telithromycin in streptococci in Austria, 1996-2002.
Buxbaum A; Forsthuber S; Sauermann R; Gattringer R; Graninger W; Georgopoulos A;
Int J Antimicrob Agents; 2004 Oct; 24(4):397-400. PubMed ID: 15380268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
